Atlas Trials

A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay

Clinical trial NCT01899079 · COMPLETED

Trial details

NCT number
NCT01899079
Sponsor
NanoString Technologies, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2013-06-01
Primary completion
2014-01-01
Enrollment
217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.